Total Funding
72
67
Total FundingPost-IPO Equity raised
Growth Score
-22 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51499
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.
- Setu Purohit: President, Chief Legal Officer & Co-Founder
- Aras Azadian: Co-Founder and CEO
About the Company
Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space. It provides the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms, including API, medical, pharmaceutical, and derma cosmetics. As a multinational
organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions.
Avicanna was founded in 2016 and is headquartered in Toronto, Ontario, Canada.
